ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Group 10 thiosemicarbazone metal complexes as an antiproliferative platform for head and neck squamous cell carcinoma (2026)
Miranda, Victor Maia ; Azevedo, Fernanda Van Petten de Vasconcelos ; Arruda, Joaldo Garcia ; Schibelsky, Hirya Costa; Affonso, Daniele Daiane ; Lima, Carmen Silvia Passos ; Deflon, Victor Marcelo
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Preencher dados do congresso. Unidade: IQSC
Subjects: NEOPLASIAS, ELEMENTOS DE TRANSIÇÃO, NÍQUEL, PALÁDIO, PLATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Victor Maia et al. Group 10 thiosemicarbazone metal complexes as an antiproliferative platform for head and neck squamous cell carcinoma. Hematology, Transfusion and Cell Therapy. São Paulo: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2026.106300. Acesso em: 23 abr. 2026. , 2026
APA
Miranda, V. M., Azevedo, F. V. P. de V., Arruda, J. G., Schibelsky, H. C., Affonso, D. D., Lima, C. S. P., & Deflon, V. M. (2026). Group 10 thiosemicarbazone metal complexes as an antiproliferative platform for head and neck squamous cell carcinoma. Hematology, Transfusion and Cell Therapy. São Paulo: Instituto de Química de São Carlos, Universidade de São Paulo. doi:10.1016/j.htct.2026.106300
NLM
Miranda VM, Azevedo FVP de V, Arruda JG, Schibelsky HC, Affonso DD, Lima CSP, Deflon VM. Group 10 thiosemicarbazone metal complexes as an antiproliferative platform for head and neck squamous cell carcinoma [Internet]. Hematology, Transfusion and Cell Therapy. 2026 ; 48 106300.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/j.htct.2026.106300
Vancouver
Miranda VM, Azevedo FVP de V, Arruda JG, Schibelsky HC, Affonso DD, Lima CSP, Deflon VM. Group 10 thiosemicarbazone metal complexes as an antiproliferative platform for head and neck squamous cell carcinoma [Internet]. Hematology, Transfusion and Cell Therapy. 2026 ; 48 106300.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/j.htct.2026.106300
Trabalho de evento-resumo periodico
Development of a bifunctional chelator for gallium aiming for theranostic application in nuclear medicine (2026)
Arruda, Joaldo Garcia ; Marques, Fabio Luiz Navarro ; Fernandez, Célia M.C.; Paulo, António R. ; Deflon, Victor Marcelo
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Preencher dados do congresso. Unidades: FM, IQSC
Subjects: MEDICINA NUCLEAR, RADIOISÓTOPOS, GÁLIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Joaldo Garcia et al. Development of a bifunctional chelator for gallium aiming for theranostic application in nuclear medicine. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2026.106295. Acesso em: 23 abr. 2026. , 2026
APA
Arruda, J. G., Marques, F. L. N., Fernandez, C. M. C., Paulo, A. R., & Deflon, V. M. (2026). Development of a bifunctional chelator for gallium aiming for theranostic application in nuclear medicine. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.htct.2026.106295
NLM
Arruda JG, Marques FLN, Fernandez CMC, Paulo AR, Deflon VM. Development of a bifunctional chelator for gallium aiming for theranostic application in nuclear medicine [Internet]. Hematology, Transfusion and Cell Therapy. 2026 ; 48[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/j.htct.2026.106295
Vancouver
Arruda JG, Marques FLN, Fernandez CMC, Paulo AR, Deflon VM. Development of a bifunctional chelator for gallium aiming for theranostic application in nuclear medicine [Internet]. Hematology, Transfusion and Cell Therapy. 2026 ; 48[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/j.htct.2026.106295
Trabalho de evento-resumo periodico
Development of a new trivalent chelating agent and study of its complexation to form a complex with oxorrhenium(V) (2026)
Gomes, Julia Pontes; Deflon, Victor Marcelo
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Preencher dados do congresso. Unidade: IQSC
Subjects: MEDICINA NUCLEAR, RADIOTRAÇADORES, LIGANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Julia Pontes e DEFLON, Victor Marcelo. Development of a new trivalent chelating agent and study of its complexation to form a complex with oxorrhenium(V). Hematology, Transfusion and Cell Therapy. São Paulo: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2026.106289. Acesso em: 23 abr. 2026. , 2026
APA
Gomes, J. P., & Deflon, V. M. (2026). Development of a new trivalent chelating agent and study of its complexation to form a complex with oxorrhenium(V). Hematology, Transfusion and Cell Therapy. São Paulo: Instituto de Química de São Carlos, Universidade de São Paulo. doi:10.1016/j.htct.2026.106289
NLM
Gomes JP, Deflon VM. Development of a new trivalent chelating agent and study of its complexation to form a complex with oxorrhenium(V) [Internet]. Hematology, Transfusion and Cell Therapy. 2026 ; 48 106289.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/j.htct.2026.106289
Vancouver
Gomes JP, Deflon VM. Development of a new trivalent chelating agent and study of its complexation to form a complex with oxorrhenium(V) [Internet]. Hematology, Transfusion and Cell Therapy. 2026 ; 48 106289.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/j.htct.2026.106289
Trabalho de evento-resumo periodico
Preliminary study of radiolabeling of anti-EGFR peptide using the novel chelator via the technetium-99m pertechnetate route (2026)
Souza, Aline Morais de; Carvalheira, Leonardo Yumoto ; Miranda, Victor Maia ; Marques, Fabio Luiz Navarro ; Deflon, Victor Marcelo ; Malavolta, Luciana
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Preencher dados do congresso. Unidades: FM, IQSC
Subjects: QUÍMICA NUCLEAR, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Aline Morais de et al. Preliminary study of radiolabeling of anti-EGFR peptide using the novel chelator via the technetium-99m pertechnetate route. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2026.106282. Acesso em: 23 abr. 2026. , 2026
APA
Souza, A. M. de, Carvalheira, L. Y., Miranda, V. M., Marques, F. L. N., Deflon, V. M., & Malavolta, L. (2026). Preliminary study of radiolabeling of anti-EGFR peptide using the novel chelator via the technetium-99m pertechnetate route. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.htct.2026.106282
NLM
Souza AM de, Carvalheira LY, Miranda VM, Marques FLN, Deflon VM, Malavolta L. Preliminary study of radiolabeling of anti-EGFR peptide using the novel chelator via the technetium-99m pertechnetate route [Internet]. Hematology, Transfusion and Cell Therapy. 2026 ; 48 106282.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/j.htct.2026.106282
Vancouver
Souza AM de, Carvalheira LY, Miranda VM, Marques FLN, Deflon VM, Malavolta L. Preliminary study of radiolabeling of anti-EGFR peptide using the novel chelator via the technetium-99m pertechnetate route [Internet]. Hematology, Transfusion and Cell Therapy. 2026 ; 48 106282.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/j.htct.2026.106282

USP Schools

ReP

Filtros

Authors

Subjects